M. D. Rawlins
Impact in
- Pharmacology top 0.1%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Toxicology top 0.2%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Pharmacology 36
- Pharmacogenetics and Drug Metabolism 23
- Drug-Induced Hepatotoxicity and Protection 11
- Toxicology 14
- Pharmacovigilance and Adverse Drug Reactions 13
- Co-authors
- Anthony J. CulyerHilary WynnePaul WainwrightJ WeilMichael S. MurphyD G Colin‐JonesMartin VesseyDavid H. Lawson
- Journals
- European Journal of Clinical Pharmacology (38 papers)The Lancet (22 papers)British Journal of Clinical Pharmacology (9 papers)Age and Ageing (9 papers)Biochemical Pharmacology (5 papers)
- Partner nations
- United KingdomSwedenUnited States
In The Last Decade
M. D. Rawlins
211 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 192
- Pharmacology 1.3k
- Toxicology 453
- Geriatrics and Gerontology 417
- Pharmacology 1.6k
- Pediatrics, Perinatology and Child Health 1.3k
Countries citing papers authored by M. D. Rawlins
This map shows the geographic impact of M. D. Rawlins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. D. Rawlins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. D. Rawlins more than expected).
Fields of papers citing papers by M. D. Rawlins
This network shows the impact of papers produced by M. D. Rawlins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. D. Rawlins. The network helps show where M. D. Rawlins may publish in the future.
Co-authors
The 25 scholars most cited alongside M. D. Rawlins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 40 | |
| 2 | 2014 | 4 | |
| 3 | 2013 | 19 | |
| 4 | 2013 | 13 | |
| 5 | 2009 | 17 | |
| 6 | The HSJ debate. Quality-adjusted life years are too rigid a yardstick for the NHS. | 2005 | 0 |
| 7 | 2002 | 189 | |
| 8 | 1999 | 121 | |
| 9 | 1998 | 50 | |
| 10 | 1995 | 14 | |
| 11 | Attitudes to adverse drug reaction reporting in the Northern Region. | 1992 | 82 |
| 12 | 1989 | 27 | |
| 13 | 1988 | 18 | |
| 14 | 1987 | 6 | |
| 15 | 1985 | 74 | |
| 16 | Drug metabolism and disposition : considerations in clinical pharmacology | 1985 | 24 |
| 17 | 1981 | 11 | |
| 18 | 1981 | 44 | |
| 19 | 1980 | 24 | |
| 20 | 1975 | 26 |
About M. D. Rawlins
M. D. Rawlins is a scholar working on Pharmacology, Toxicology, Pharmacology, Pediatrics, Perinatology and Child Health and Critical Care and Intensive Care Medicine, having authored 221 papers that have together received 8.6k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (32 papers), Pharmacogenetics and Drug Metabolism (23 papers), Pharmaceutical studies and practices (18 papers), Pharmacological Effects and Toxicity Studies (15 papers), Pharmacovigilance and Adverse Drug Reactions (13 papers), Epilepsy research and treatment (12 papers), Healthcare cost, quality, practices (11 papers) and Drug-Induced Hepatotoxicity and Protection (11 papers). The work is most often cited by research in Pharmacology (1.3k citations), Toxicology (453 citations), Geriatrics and Gerontology (417 citations), Pharmacology (1.6k citations) and Pediatrics, Perinatology and Child Health (1.3k citations). M. D. Rawlins has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Anthony J. Culyer, Hilary Wynne, Paul Wainwright, J Weil, Michael S. Murphy, D G Colin‐Jones, Martin Vessey, David H. Lawson, Oliver James and K.W. Woodhouse. Their work appears in journals such as European Journal of Clinical Pharmacology, The Lancet, British Journal of Clinical Pharmacology, Age and Ageing and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.